Catalysis: A key technology for a green approach to pharmaceutical production
Rendiconti Lincei, ISSN: 1720-0776, Vol: 18, Issue: 4, Page: 271-280
2007
- 4Citations
- 10Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Catalysis is the key technology for the development of green processes for the industrial production of active pharmaceutical ingredients. The design of green, efficient and cost competitive industrial process of idarubicin, erlotinib and ivermectin shows the central role of catalysis. © 2007 Springer.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84867991766&origin=inward; http://dx.doi.org/10.1007/bf02934924; http://link.springer.com/10.1007/BF02934924; http://www.springerlink.com/index/pdf/10.1007/BF02934924; https://dx.doi.org/10.1007/bf02934924; https://link.springer.com/article/10.1007/BF02934924; http://www.springerlink.com/index/10.1007/BF02934924
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know